Pharmacokinetics and elimination efficiency of linezolid during dialysis

Renal Failure

Volumn 35, Issue 3, 2013, Pages 418-420

  Hiraki, Yoichi ^a   Tsuji, Yasuhiro ^b   Misumi, Nobuhiro ^c   Hiraike, Mikako ^a   Matsumoto, Kana ^d   Morita, Kunihiko ^d   Kamimura, Hidetoshi ^e   Karube, Yoshiharu ^e  

^a NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^d DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

^e FUKUOKA UNIVERSITY   (Japan)

Author keywords

Concentration; Dialysis; Linezolid; Myelosuppression; Protein binding rate

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATININE; LINEZOLID; MEROPENEM; NITROGEN; UREA; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; OXAZOLIDINONE DERIVATIVE;

AGED; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG PROTEIN BINDING; FEMALE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FUNCTION; LEUKOCYTE COUNT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL; AMPUTATION; BACTEREMIA; BLOOD; COMPLICATION; KIDNEY FAILURE, CHRONIC; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; RENAL REPLACEMENT THERAPY; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION;

ACETAMIDES; AGED; AMPUTATION; ANTI-INFECTIVE AGENTS; BACTEREMIA; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OXAZOLIDINONES; RENAL DIALYSIS; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION;

EID: 84875041376     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.761085     Document Type: Article

References (19)

1. Zurenko GE, Gibson JK, Shinabarger DL, Aristoff PA, Ford CW, Tarpley WG. Oxazolidinones: A new class of antibacterials. Curr Opin Pharmacol. 2001;1(5):470-476
2. Mascini EM, Troelstra A, Beitsma M, et al. Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium. Clin Infect Dis. 2006;42(6):739-746
3. Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 2003;348(14):1342-1347
4. Wunderink RG, Niederman MS, Kollef MH, et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: A randomized, controlled study. Clin Infect Dis. 2012;54(5):621-629
5. Pfizer. Co. ZYVOX (linezolid) Label Information Retrieved (June 20). 2008
6. Stalker DJ, Jungbluth GL. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial. Clin Pharmacokinet. 2003;42(13):1129-1140
7. Hiraki Y, Tsuji Y, Hiraike M, et al. Correlation between serum linezolid concentration and the development of thrombocytopenia. Scand J Infect Dis. 2012;44(1):60-64
8. Hiraki Y, Tsuji Y, Matsumoto K, Morita K, Kamimura H, Karube Y. Influence of linezolid clearance on the induction of thrombocytopenia and reduction of hemoglobin. Am J Med Sci. 2011;342:456-460
9. Tsuji Y, Hiraki Y, Mizoguchi A, et al. Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure. J Infect Chemoth. 2008;14(2):156-160
10. Majcher-Peszynska J, Haase G, Sass M, et al. Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections. Eur J Clin Pharmacol. 2008;64(11):1093-1100
11. Dixon JR Jr. The international conference on harmonization good clinical practice guideline. Qual Assur. 1998;6(2):65-74
12. Declaration of Helsinki. Ethical principles for medical research involving human subjects. J Indian Med Assoc. 2009;107(6): 403-405
13. Brier ME, Stalker DJ, Aronoff GR, et al. Pharmacokinetics of linezolid in subjects with renal dysfunction. Antimicrob Agents Chemother. 2003;47(9):2775-2780
14. Matsumoto K, Takeshita A, Ikawa K, et al. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction. Int J Antimicrob Agents. 2010;36(2):179-181
15. Bernstein WB, Trotta RF, Rector JT, Tjaden JA, Barile AJ. Mechanisms for linezolid-induced anemia and thrombocytopenia. Ann Pharmacother. 2003;37(4):517-520
16. Kaufman DW, Kelly JP, Johannes CB, et al. Acute thrombocytopenic purpura in relation to the use of drugs. Blood. 1993;82 (9):2714-2718
17. Chong BH, Du XP, Berndt MC, Horn S, Chesterman CN. Characterization of the binding domains on platelet glycoproteins Ib-IX and IIb/IIIa complexes for the quinine/quinidinedependent antibodies. Blood. 1991;77(10):2190-2199
18. Sachais BS, Litvinov RI, Yarovoi SV, et al. Dynamic antibodybinding properties in the pathogenesis of HIT. Blood. 2012;120(5):1137-1142
19. Wu VC, Wang YT, Wang CY, et al. High frequency of linezolidassociated thrombocytopenia and anemia among patients with end-stage renal disease. Clin Infect Dis. 2006;42(1):66-72